Tradestie Institutional Equity Comparison Engine

SRPT vs ACAD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRPT Overall Edge

SRPT Captures Institutional Edge (3โ€“1 Pillars ยท 2โ€“8 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sarepta Therapeutics,, Inc. Common Stock (SRPT) driven by superior Valuation, Momentum & Technical, Options & Structure while ACAD counters with relative strength in Growth & Margin. Fundamentally, SRPT trades at 10.8x Forward P/E with -0.4% operating margin (-4.5% YoY revenue) versus ACAD at 17.8x Forward P/E and 10.2% operating margin (+22.8% YoY). In options structure, SRPT sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against ACAD sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SRPT
SRPT 10.8x vs ACAD 17.8x Fwd P/E
Growth & Margin Winner ACAD
Op Margin -0.4% vs 10.2% ยท YoY -4.5% vs +22.8%
Momentum & Technical Winner SRPT
1Y -15.0% vs -19.3% ยท 52W Pos 5% vs 21%
Options & Structure Winner SRPT
BREAKDOWN (7th %ile IV) vs BREAKDOWN (4th %ile IV)
SRPT NASDAQ
Sarepta Therapeutics,, Inc. Common Stock
Pharmaceutical Preparations
$15.14
-5.76% 1D
Market Cap $1.7B
1M Return -11.44%
1Y Return -15.02%
Forward P/E 10.8x
Unified AI Score
37.8 / 100 SELL
Tech 32.0 Fund 51.0 Flow 71.0 Mom 60.0
ACAD NASDAQ
Acadia Pharmaceuticals Inc.
Pharmaceutical Preparations
$19.07
+1.71% 1D
Market Cap $3.1B
1M Return -0.26%
1Y Return -19.33%
Forward P/E 17.8x
Unified AI Score
42.0 / 100 HOLD
Tech 43.0 Fund 52.0 Flow 68.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SRPT -15.02% ACAD -19.33% Spread: +4.31 pp (SRPT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SRPT Revenue ACAD Revenue SRPT Op. Margin ACAD Op. Margin Margin Edge
FY2018 $300M $220M -114.1% -110.6% ACAD
FY2019 $380M $340M -185.3% -72.7% ACAD
FY2020 $460M $440M -123.8% -64.9% ACAD
FY2021 $610M $480M -75.1% -35.2% ACAD
FY2022 $840M $520M -63.5% -43.2% ACAD
FY2023 $1.14B $730M -23.4% -10.1% ACAD
FY2024 $1.79B $960M 12.2% 24.1% ACAD
FY2025 $1.86B $1.07B -37.5% 9.8% ACAD

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SRPT (2) vs ACAD (8)
Institutional Metric SRPT ACAD Criterion Row Winner
Market Capitalization Scale $1.7B $3.1B Larger Scale ACAD
Trailing P/E Ratio Valuation N/M 8.6x Lower Multiple ACAD
Forward P/E Ratio Valuation 10.8x 17.8x Lower Multiple SRPT
Revenue Growth (YoY) Growth -4.5% +22.8% Higher Growth ACAD
Operating Margin (TTM) Profitability -0.4% 10.2% Higher Margin ACAD
Net Profit Margin Profitability -5.9% 30.1% Higher Margin ACAD
Return on Equity (ROE) Capital Efficiency -8.1% 31.4% Higher ROE ACAD
52-Week Range Position Momentum 5% ($15โ€“$25) 21% ($16โ€“$31) Stronger Trend ACAD
Beta / 30D Volatility Risk Regime 1.47ฮฒ ยท 58% Vol 0.11ฮฒ ยท 93% Vol Lower Realized Risk SRPT
Unified Institutional Score Composite Signal 37.8 / 100 (SELL) 42.0 / 100 (HOLD) Higher Composite ACAD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SRPT vs ACAD Buy Guide
SRPT BREAKDOWN
52d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live SRPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACAD BREAKDOWN
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live ACAD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SRPT nor ACAD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.